Supplementary Figure S5 from ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial
Authors:
- Ross A. SooRSRoss A. Soo
- Urania DafniUDUrania Dafni
- Ji-Youn HanJHJi-Youn Han
- Byoung Chul ChoBCByoung Chul Cho
- Ernest NadalErnest Nadal
- Chong Ming YeoCYChong Ming Yeo
- Enric CarcerenyECEnric Carcereny
- Javier de CastroJCJavier de Castro
- Maria Angeles SalaMSMaria Angeles Sala
- Linda CoateLCLinda Coate
- Mariano ProvencioMPMariano Provencio
- Christian BritschgiCBChristian Britschgi
Open Access
- 15 November 2024
- other
- Published by American Association for Cancer Research (AACR)